OSRX Launches AutoRefill Program to Put Patients Ahead of Profits
OSRX Launches AutoRefill Program
to Put Patients Ahead of Profits
With prices climbing on everything from eggs to electricity, OSRX® is doubling down on what matters most: putting patients first. The 503B ophthalmic compounding pharmacy has officially launched its AutoRefill Program, providing patients nationwide with consistent access to trusted combination therapy medications – including Brimonidine Tartrate 0.1% + Dorzolamide 2% and Timolol 0.5% + Bimatoprost 0.01% – at up to 60% below retail pricing.
“It’s simple—we’re in this to serve vulnerable patient populations, not line our pockets,” said Eric Garner, Chief Commercial Officer of OSRX. “This AutoRefill Program is one more example of how we’re making quality medicine accessible. Fewer roadblocks, more common-sense solutions. That’s the OSRX way.”
Access Matters. The Numbers Tell the Story.
Refill delays, insurance red tape, and rising drug costs continue to disrupt care for patients and providers alike.
- 1 in 5 patients with chronic eye conditions ask for lower-cost options (NHIS).
- Nearly 30% of long-term drop users skip treatment, doses, or refills due to access or cost (JAMA Ophthalmology).
- 93% of physicians say prior authorizations delay care; 82% say they can lead to treatment abandonment (AMA).
- Pharmacy call-backs due to stock issues, costs, or refill confusion are a growing burden (Ophthalmology Management).
Note: Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality. Click here to view potential adverse events and contraindications.
The OSRX AutoRefill Program helps solve these issues with:
- Medications starting at just $20
- Up to 60% off retail pricing
- No insurance or prior authorizations required
- Free direct-to-patient delivery
- Seamless, pharmacy-managed refills
Dr. Shachar Tauber, Director of Ophthalmology Research, Cornea and Refractive Surgery at Mercy Clinic in Springfield, MO, was eager to add his thoughts on the program: “Today, the ophthalmologist must be more than just a prescriber. We have to listen—really listen—to our patients: their ability to tolerate treatment, manage long-term care, and afford what often becomes a lifelong routine. Chronic eye conditions demand that we step in as advocates, not just physicians.
The OSRX AutoRefill program is an incredible tool that helps me do just that. It delivers high-quality compounded medications directly to my patients at an excellent price—and it gives me real confidence they’re staying on track. I’m truly grateful for that.”
New Formulations Now Available Through AutoRefill
As part of the program’s debut, OSRX has added two new 5mL sterile ophthalmic solutions —available exclusively at discounted AutoRefill pricing:
- Bimatoprost 0.01% + Dorzolamide 2% + Timolol 0.5% — $25
- Bimatoprost 0.01% + Brimonidine Tartrate 0.1% + Dorzolamide 2% — $25
These join a growing portfolio of 5mL multi-agent drops eligible for AutoRefill pricing:
- Brimonidine Tartrate 0.1% + Dorzolamide 2% — $25
- Timolol 0.5% + Bimatoprost 0.01% — $20
- Timolol 0.5% + Brimonidine 0.1% + Dorzolamide 2% — $25
- Timolol 0.5% + Brimonidine 0.1% + Dorzolamide 2% + Bimatoprost 0.01% — $27
Note: Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality. Click here to view potential adverse events and contraindications.
Simple for Providers. Seamless for Patients.
Prescribers can activate AutoRefill pricing by using code COMBORX via eRx or the OSRX Prescriber Portal (with at least one refill included). No insurance paperwork. No prior auths. Just fast, affordable access.
How it works:
- Provider submits the prescription
- OSRX sends a secure text/email link to the patient
- Patient confirms shipping and payment details
- Prescription ships via free USPS First-Class Mail (3-7 business days)
Patients can opt in at payment —or call anytime to enroll.
Here’s What an Improved Patient Experience Looks Like.
At OSRX, we zig where others zag—engineering simple solutions to solve complex problems. That means delivering high-quality compounded medications that are affordable, accessible, and easy to use.
Thousands of prescribers nationwide already trust OSRX to support their practices and simplify the patient journey.
Schedule a call to learn how AutoRefill can benefit your practice and your patients.
About OSRX®
Based in Missoula, Montana, OSRX is a 503B outsourcing facility specializing in compounded sterile ophthalmic medications. With thousands of trusted prescribers, OSRX is reshaping the patient experience by offering simplified, affordable care solutions. We have A New View of Medicine®.
Professional Disclosure: Dr. Tauber is a Medical Advisory Board Member for Ocular Science® (an OSRX affiliate) and has a financial interest in the company.
Patients can opt out of AutoRefill at any time by contacting our pharmacy. Combination therapy medications carry serious risks, including burning and stinging upon instillation, allergic conjunctivitis and bitter taste in mouth. Click here to view potential adverse events and contraindications. For professional use only. OSRX specializes in customizing compounded medications to meet unique patient needs. Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality.